PHARMACYTE BIOTECH, INC.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2018
Total Assets: $6.4M
Liabilities Breakdown FY2018
Total Liabilities: $644.2K
Asset Breakdown
Total Assets: $6.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.4M | 100.0% |
Liabilities Breakdown
Total Liabilities: $644.2K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $352.6K | 54.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $291.5K | 45.3% |